Related Experiment Videos
Reversible obstructive hypertrophic cardiomyopathy in the Beckwith-Wiedemann syndrome
C A Ryan1, M H Boyle, G W Burggraf
1Department of Paediatrics, Queen's University, Hotel Dieu Hospital, Kingston, Ontario, Canada.
Insights
Beckwith-Wiedemann syndrome patients face higher risks of heart issues. This study details a case of reversible obstructive hypertrophic cardiomyopathy linked to metabolic factors in Beckwith-Wiedemann syndrome.
Area of Science:
- Pediatric Cardiology
- Genetics
- Metabolic Disorders
Background:
- Beckwith-Wiedemann syndrome (BWS) is associated with an elevated risk of congenital heart disease.
- Previous reports suggest a link between BWS and idiopathic cardiomegaly on chest X-rays.
Observation:
- A specific infant case presented with obstructive hypertrophic cardiomyopathy.
- This condition was documented and monitored over time.
Findings:
- The infant's hypertrophic cardiomyopathy was found to be reversible.
- The study explores the connection between this cardiac condition and the metabolic characteristics of BWS.
Implications:
- Understanding the link between BWS metabolic features and cardiomyopathy is crucial for patient management.
- This case highlights the potential for reversible cardiac dysfunction in BWS patients.
- Further research into BWS-related metabolic pathways could reveal novel therapeutic targets for cardiac complications.
Abstract:
Patients with the Beckwith-Wiedemann (B-W) syndrome have been reported to have an increased risk of congenital heart disease and of idiopathic cardiomegaly on chest x-ray. In the infant described here, reversible obstructive hypertrophic cardiomyopathy was documented and its relationship to the metabolic features of the B-W syndrome is discussed.